View Older Stories
-
BioHarvest Sciences completes stage 1 saffron development program
-
BioHarvest Sciences Announces Successful Completion of Stage 1 Development of Saffron Composition for Nutraceutical and Culinary Applications
-
BioHarvest Sciences secures $1.2M contract for rare fragrance development
-
BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using Its Proprietary Botanical Synthesis Platform
-
BioHarvest Sciences to Report First Quarter 2026 Financial Results on May 14, 2026
-
BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate "Two-Lens" Growth Strategy
-
H.C. Wainwright Reiterates Buy Rating on BioHarvest Sciences (BHST)
-
BioHarvest Sciences Reports Fourth Quarter and Full-Year 2025 Financial Results
-
BioHarvest Sciences develops stable cell culture for rare fragrance plant
-
BioHarvest Sciences Announces First-Ever Successful Stable Cell Culture Development of Rare Fragrance-Producing Plant Using Proprietary Botanical Synthesis Platform
-
BioHarvest says VINIA becomes top US resveratrol supplement brand
-
BioHarvest Sciences Announces that VINIA is Now the No.1 Resveratrol Polyphenol Brand in the United States
-
BioHarvest Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026
-
BioHarvest Sciences Announces Grant of Long-Term Incentive Awards to Employees, Officers and Directors
-
BioHarvest Sciences appoints Prof. Hezi Levy to board
-
BioHarvest Sciences Announces Board Transition and Appointment of Prof. Hezi Levy
-
BioHarvest Sciences to Participate in 38th Annual Roth Conference on March 22-24, 2026
-
Barclays Downgrades BASF SE (BAS:GR) (BASFY) to Underweight
-
Roth/MKM Starts BioHarvest Sciences (BHST) at Buy
-
BioHarvest Sciences Issues Year End Shareholder Letter
-
BioHarvest Sciences receives $1.6 million grant from Israeli authority
-
BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform
-
BioHarvest Sciences launches VINIA blood flow hydration product
-
BioHarvest Sciences Announces Launch of VINIA Blood Flow Hydration Product
-
BioHarvest Sciences Reports Third Quarter 2025 Financial Results
-
BioHarvest Sciences to Attend the Craig-Hallum 16th Annual Alpha Select Conference on November 18, 2025
-
BioHarvest Sciences closes $19.9 million public offering
-
BioHarvest Sciences Announces Closing of $19.9 Million Upsized Public Offering of Common Stock and Exercise of Underwriter's Option to Purchase Additional Shares
-
BioHarvest Sciences prices $17.4 million public offering at $7 per share
-
BioHarvest Sciences Announces Pricing of $17.4 Million Upsized Public Offering of Common Stock
-
BioHarvest announces underwritten public offering of common stock
-
BioHarvest Announces Proposed Public Offering of Common Stock
-
BioHarvest Sciences to Host Third Quarter Earnings Call on November 13 at 4:30 p.m. Eastern Time
-
BioHarvest Sciences partners with Saffron Tech for compound production
-
BioHarvest Sciences Announces Strategic CDMO Partnership to Revolutionize Saffron Compound Production with Botanical Synthesis
-
BioHarvest Sciences raises $10.9 million, reduces debt by $3.8 million
-
BioHarvest Sciences Strengthens Balance Sheet by $14.7 Million with Injection of $10.9 Million Gross Proceeds and Additional $3.8 Million in Debt Reduction
-
BioHarvest Sciences produces plant-based exosomes at commercial scale
-
BioHarvest Sciences Announces Breakthrough in Botanical Synthesis Capabilities with Plant-Based Exosome Production at Scale
-
BioHarvest Sciences to Host a Virtual Investor Webinar on September 10, 2025 at 1:00 PM ET
-
BioHarvest Sciences Reports Second Quarter 2025 Financial Results
-
BioHarvest Sciences to Host Second Quarter 2025 Earnings Call on August 11 at 8:00 a.m. Eastern Time
-
BioHarvest Sciences to Present at Canaccord Genuity 45th Annual Growth Conference on August 12-14, 2025
-
BioHarvest Launches Informed Sport-Certified VINIA DailyChews 2X Formula for Athletes and People with Active Lifestyles
-
BioHarvest (BHST) secures new contract for plant-based fragrance development
-
BioHarvest Secures New CDMO Contract to Develop Plant-based Fragrance Compound
-
BioHarvest Sciences Reports First Quarter 2025 Financial Results
-
BioHarvest Announces Completion of Stage 1 Development for CDMO Contract with Nasdaq-Listed Pharmaceutical Company
-
Craig-Hallum Starts BioHarvest Sciences (BHST) at Buy
-
BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time
